GLP-1 withdrawal linked to higher cardiovascular risk, study warns

A Washington University School of Medicine study suggests that discontinuing GLP-1 drugs like Ozempic may increase the risk of heart attack, stroke, and death. The finding is based on analysis of patient outcomes after treatment cessation, though causality and effect size remain uncertain. This could influence prescribing practices and patient adherence, with potential implications for public health and pharmaceutical markets.